GRM2 and renal cell carcinoma: These data suggest that ALDOA, ARNT, C3, CALM1, CAMK2A, CCL28, CCR1, CCR2, CCR3, CCR4, CCR5, CCR8, CCR9, CCRL2, CDC42, CSNK1A1, CX3CR1, CXCR6, DRD3, GNAI2, GNB1, GNB2, GNGT1, GRK6, GRM6, GRM7, HEBP1, HGS, 1L12B, 1L23A, NMUR2, PDGFRB, PIK3CA, PPKCD, PTGER3, PTPN11, PXN, RAC1, RALB, SPARC, SSTR4, STAT2, STAT3, TAS2R3, TAS2R31, TAS2R4, VWF, WNT5A, XCR1, and GRM2 were primarily associated with the modulation and function of differentially expressed CXC chemokines in RCC (Figure 7E).